Inspirna raises funds to advance clinical stage cancer drugs development

Inspirna has raised $50m in Series D financing round to advance the development of its clinical stage cancer drugs. New investors Sands Capital

Related Keywords

New York ,United States ,Masoud Tavazoie ,Sixty Degree Capital Fund ,York City Investment Fund ,Sands Capital ,Vivo Capital ,New York City Investment Fund ,